Cambridge-based femtech Ablatus has secured backing from Keiretsu Forum London Angels to support its soft tissue treatment technology.
Ablatus
Ablatus develops Luna, a treatment system for soft tissues like tumours and fibroids.
Cambridge-based medical technology company Ablatus develops Luna, a treatment system for soft tissues such as tumours and fibroids.
Categories
Team
CL
Chung Looi
Chung brings health and medtech operating experience, including roles as chief executive at Ablatus Therapeutics and partnerships director at Oxford VR. An Oxford PhD graduate, she also advises boards across the life sciences sector.
LinkedIn